Background illustration for clinical trials search

Paid Clinical Trials New Haven

Discover 1,147 paid clinical trials in New Haven, Connecticut. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Prospective Case Series Evaluating 6-Month and 12-Month Outcomes After Cryoneurolysis for Chronic Pain

for
Chronic Pain, PERIPHERAL NEUROPATHY, Occipital Neuralgia,
Location: Old Saybrook CT
Sponsor: Yale University

Sex: All

Age: 18+

Code: NCT07639060

Recruiting

Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease

for
Triple Negative Breast Cancer, Non Small Cell Lung Cancer,
Location: Norwalk CT, Hartford CT, Commack NY, Harrison NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT03808337

Phase2, Recruiting

Study of 3-Day Partial Breast Radiation Therapy in Women With Breast Cancer

for
Invasive Ductal Breast Carcinoma,
Location: Norwalk CT, Commack NY, Harrison NY, Uniondale NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: Female

Age: 45+

Code: NCT04084730

Phase2, Recruiting

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

for
Cancer Harboring BRAF Alterations, HGG, LGG, Solid Tumors
Location: Norwalk CT, New York NY, Summit NJ, Providence RI,
Sponsor: Fore Biotherapeutics

Sex: All

Age: 8+

Code: NCT05503797

Phase2, Recruiting

Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)

for
Atrial Fibrillation (AF)
Location: Stony Brook NY, Stamford CT, Hauppauge NY, Valhalla NY,
Sponsor: Anthos Therapeutics, Inc.

Sex: All

Age: 65+

Code: NCT05712200

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)

for
Non Small Cell Lung Cancer
Location: Stony Brook NY, Stamford CT, White Plains NY,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06312137

Phase3, Recruiting

Perivenous Dexamethasone Therapy: Examining Reduction of Inflammation After Thrombus Removal to Yield Benefit in Acute Femoropopliteal DVT

for
Thrombosis, Deep Vein, Iliofemoral; Thrombosis
Location: Stony Brook NY, Darien CT, Englewood NJ, Hyattsville MD,
Sponsor: Mercator MedSystems, Inc.

Sex: All

Age: 18 - 70+

Code: NCT04862468

Phase2, Recruiting

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

for
Down Syndrome, Recurrent B Acute Lymphoblastic Leukemia
Location: Stony Brook NY, Hartford CT, Mineola NY,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 1 - 30

Code: NCT04546399

Phase2, Recruiting

Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)

for
Triple Negative Breast Cancer
Location: Stony Brook NY, Stamford CT, Shirley NY,
Sponsor: Gilead Sciences

Sex: All

Age: 18+

Code: NCT05633654

Phase3, Recruiting

Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer

for
Hematopoietic and Lymphatic System Neoplasm,
Location: Stony Brook NY, Hartford CT, The Bronx NY, New York NY,
Sponsor: Children's Oncology Group

Sex: Female

Age: 0 - 39

Code: NCT06513962

Phase3, Recruiting

A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)

for
Relapsing Multiple Sclerosis, Multiple Sclerosis
Location: Farmington CT, Hartford CT, New York NY, Teaneck NJ,
Sponsor: TG Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06433752

Recruiting

The Impact of Blood Flow Restriction Training in Adolescents After ACL Reconstruction: A Randomized Controlled Trial

for
Anterior Cruciate Ligament Injuries, Knee Injuries,
Location: Farmington CT
Sponsor: Connecticut Children's Medical Center

Sex: All

Age: 12 - 18

Code: NCT05754632

Recruiting

Study of BHV-1400 in IgA Nephropathy

for
IgA Nephropathy
Location: Farmington CT, Shelby MI, Indianapolis IN, Hinsdale IL,
Sponsor: Biohaven Therapeutics Ltd.

Sex: All

Age: 18 - 65

Code: NCT07054684

Phase1, Recruiting

Beta-blocker Discontinuation in Heart Failure With Preserved Ejection Fraction

for
Heart Failure With Preserved Ejection Fraction
Location: Farmington CT
Sponsor: UConn Health

Sex: All

Age: 50 - 70+

Code: NCT05174351

Recruiting

Parkinson's Foundation PD GENEration Genetic Registry

for
Parkinson's Disease
Location: Farmington CT, New York NY, Boston MA, Philadelphia PA,
Sponsor: Parkinson's Foundation

Sex: All

Age: 18+

Code: NCT04994015

Recruiting

Novel Approaches to the Treatment of Hypothyroidism

for
Hypothyroidism
Location: Farmington CT
Sponsor: UConn Health

Sex: All

Age: 18+

Code: NCT06731764

Phase2, Phase3, Recruiting

Genetic and Functional Analysis of Aplasia Cutis Congenital (ACC)

for
Aplasia Cutis Congenita
Location: Farmington CT
Sponsor: UConn Health

Sex: All

Age: 0+

Code: NCT01630421

Recruiting

Obstetric Life Support, a Curriculum to Effectively Resuscitate Pregnant Patients Experiencing Cardiac Arrest.

for
Cardiac Arrest, Pregnancy Related
Location: Farmington CT
Sponsor: UConn Health

Sex: All

Age: 18+

Code: NCT05355519

Recruiting

Circulating Markers That Underlie the Transition From Compensated Hypertrophy to Heart Failure

for
Acute Decompensated Heart Failure, Heart Failure
Location: Farmington CT
Sponsor: UConn Health

Sex: All

Age: 18+

Code: NCT00762008

Recruiting

A Phase 1/2, Dose-Exploration Study to Evaluate the Safety and Efficacy of BEAM-301 in Patients With Glycogen Storage Disease Type Ia (GSDIa)

for
Glycogen Storage Disease Type Ia
Location: Farmington CT, Houston TX, Orange CA
Sponsor: Beam Therapeutics Inc.

Sex: All

Age: 18+

Code: NCT06735755

Phase1, Phase2, Recruiting